ライフサイエンスコーパス: conjunctival injection

1 3 of 20 (15%) had pain and 2 of 20 (10%) had conjunctival injection.

2 n, pain with ocular movement, proptosis, and conjunctival injection.

3 ) autonomic symptoms, such as lacrimation or conjunctival injection.

4 eral lacrimation of the eye, rhinorrhea, and conjunctival injection.

5 es such as corneal infiltrate, hypopyon, and conjunctival injection.

6 nced coughing, nasal drop, eyelid edema, and conjunctival injection.

7 tic precipitates (22%), corneal edema (13%), conjunctival injection (10%), chemosis (4%), hypopyon (4

8 erpalpebral conjunctival melanosis (44%) and conjunctival injection (43%).

9 Of the cohort, 87% had lacrimation, 68% had conjunctival injection, 58% rhinorrhoea, 54% nasal conge

10 % had lacrimation, 51% nasal congestion, 46% conjunctival injection and 40% ptosis and facial flushin

11 pia, proptosis (which is generally minimal), conjunctival injection and chemosis, and periorbital ede

12 manifested right eye (RE) excessive tearing, conjunctival injection and pain.

13 asting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT syndrome) and

14 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and perhaps i

15 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-las

16 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-las

17 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT) and short-las

18 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT), short-lastin

19 nilateral neuralgiform headache attacks with conjunctival injection and tearing (SUNCT; 5%), cluster

20 nilateral neuralgiform headache attacks with conjunctival injection and tearing = 7 and short-lasting

21 nilateral neuralgiform headache attacks with conjunctival injection and tearing and short-lasting uni

22 nilateral neuralgiform headache attacks with conjunctival injection and tearing have the shortest att

23 t-lasting unilateral neuralgiform pains with conjunctival injection and tearing) was made.

24 nilateral neuralgiform headache attacks with conjunctival injection and tearing, and 16 had short-las

25 nilateral neuralgiform headache attacks with conjunctival injection and tearing, and short-lasting un

26 nilateral neuralgiform headache attacks with conjunctival injection and tearing, hypnic headache and

27 All SUNCT patients had conjunctival injection and tearing.

28 nilateral neuralgiform headache attacks with conjunctival injection and tearing.

29 nilateral neuralgiform headache attacks with conjunctival injection and tearing/cranial autonomic fea

30 rointestinal symptoms, 60% had rash, 56% had conjunctival injection, and 27% had mucosal changes.

31 e dystopia, ocular motility limitation, mild conjunctival injection, and chemosis.

32 macular or maculopapular rash, arthralgias, conjunctival injection, and headache; 27% had fever (sho

33 Pathologic changes included conjunctival injection, chemosis, corneal edema, severe

34 The left eye had episcleral and conjunctival injection, clear cornea, a deep anterior ch

35 Examination of the right eye revealed severe conjunctival injection, fine diffuse keratic precipitate

36 Two SUNA patients had conjunctival injection, four had tearing, but none had b

37 Rash was present in 30 of 58 (52%), and conjunctival injection in 26 of 58 (45%) cases.

38 d associated with autonomic symptoms such as conjunctival injection, lacrimation, nasal congestion, r

39 cks were associated with ipsilateral ptosis, conjunctival injection, lacrimation, rhinorrhoea and fac

40 (83%) exhibited mucocutaneous changes, with conjunctival injection (n = 21), palmoplantar erythema (

41 of IL-11 were mild (peripheral edema, n = 7; conjunctival injection, n = 7; myalgia, n = 1; all grade

42 elayed presentation were more likely to have conjunctival injection on initial examination (delayed,

43 t injection typically presents without pain, conjunctival injection, or hypopyon, and responds to top

44 ategory 1, including a greater proportion of conjunctival injection (P = 0.003), conjunctival corkscr

45 eculectomy 10 years prior and presented with conjunctival injection, perforated bleb, and hypotony.

46 orted ocular pain (median, 7 on scale 1-10), conjunctival injection, photophobia, foreign body sensat

47 Inflammation (ie, conjunctival injection, presence of keratic precipitates

48 orneal neovascularization, corneal staining, conjunctival injection, tarsal abnormalities or any othe